Aditxt (NASDAQ:ADTX) Releases Earnings Results

Aditxt (NASDAQ:ADTX) issued its earnings results on Monday. The company reported ($548.78) EPS for the quarter, FiscalAI reports. The business had revenue of $0.00 million during the quarter. Aditxt had a negative net margin of 206,431.38% and a negative return on equity of 316.98%.

Aditxt Trading Down 3.8%

Shares of ADTX stock opened at $4.08 on Wednesday. The company’s 50-day moving average price is $56.07 and its 200-day moving average price is $116.65. The stock has a market cap of $163,200.00, a price-to-earnings ratio of 0.00 and a beta of 1.41. Aditxt has a twelve month low of $4.01 and a twelve month high of $11,941.27.

Hedge Funds Weigh In On Aditxt

A hedge fund recently raised its stake in Aditxt stock. IFP Advisors Inc grew its position in Aditxt, Inc. (NASDAQ:ADTX) by 66,926.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,054 shares of the company’s stock after buying an additional 10,039 shares during the period. IFP Advisors Inc owned 17.64% of Aditxt worth $45,000 as of its most recent SEC filing. Institutional investors and hedge funds own 15.54% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aditxt in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Aditxt has a consensus rating of “Sell”.

About Aditxt

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.